News | Page 2 | Office of International Affairs

How SARS-CoV-2 Evolved Through the COVID Pandemic

February 6, 2025

A new study reveals how the SARS-CoV-2 virus evolved from initially prioritizing increased transmissibility to enhanced immune evasion after the Omicron variant emerged according to Weill Cornell Medicine-Qatar (WCM-Q) researchers. Over the course of the pandemic, the virus has rapidly undergone genetic mutations that have led to multiple variants with differing abilities to spread between individuals, cause severe infections and evade the immune system.

The...

Weill Cornell Medicine Welcomes Aga Khan University Leadership to discuss best practices in clinical facility design

January 14, 2025

Senior leaders from Aga Khan University and Hospital in Nairobi, Kenya, visited Weill Cornell Medicine and NewYork-Presbyterian on January 14, 2025. The delegation included Dr. Sulaiman Shahabuddin, President of Aga Khan University, Dr. Zeenat Sulaiman Khan, Regional CEO for Aga Khan Health Services in East Africa, Rashid Khalani, CEO of Aga Khan University Hospital in Nairobi, and Dr. Farhat Abbas, CEO of Aga Khan University Health Services in Pakistan.

The group visited the David H....

The International Medical Student Exchange Program Partnership with King’s College London Continues to Provide Elective Opportunities for Medical Students

November 24, 2024

Dr. Vivek Srivastava, Hospitalist and Director of Quality at King's College London (KCL), visited Weill Cornell Medicine on November 25, 2024, as part of the institutions' ongoing medical student exchange relationship. The visit focused on the quality and standards of international medical education programming, the existing exchange, and other areas where the institutions could share approaches to medical education.

Dr. Srivastava met with Dr. Michael G. Stewart, Senior Associate Dean...

Weill Cornell Medicine and Chinese University of Hong Kong Explore Collaboration Opportunities

October 2, 2024

Dr. Michael Tong, Clinical Professor and Chairman of Otorhinolaryngology at the Chinese University of Hong Kong (CUHK), visited Weill Cornell Medicine and NewYork-Presbyterian on October 2, 2024, for meetings with faculty and leadership across several clinical and research areas.

Dr. Tong met with WCM's Office of International Affairs and discussed potential collaboration in virtual education, artificial intelligence, sustainable research models, and student and faculty exchange. He...

Human ‘Molecular Map’ Contributes to the Understanding of Disease Mechanisms

September 10, 2024

Scientists at Weill Cornell Medicine in Qatar (WCM-Q) have created an intricate molecular map of the human body and its complex physiological processes based on the analysis of thousands of molecules measured in blood, urine and saliva samples from 391 volunteers. The data was integrated to create a powerful, interactive visual web-based tool called Connecting Omics (COmics) that can be used to investigate the complex...

Esteemed International Leader Dr. Javaid I. Sheikh Honored with 2024 Weill Award

June 5, 2024

Video of Weill Cornell Medicine Honors Dr. Javaid Sheikh

Dr. Javaid I. Sheikh, dean of Weill Cornell Medicine-Qatar, has been awarded the Joan and Sanford I. Weill Exemplary Achievement Award by Weill Cornell Medicine.

The Weill Award was...

Haiti Study Suggests Early-Onset Heart Failure is Prevalent Form of Heart Disease in Low-Income Countries

April 29, 2024

Early-onset heart failure is alarmingly common in urban Haiti—over 15-fold higher than previously estimated—according to a study conducted by Weill Cornell Medicine researchers in partnership with the Haitian medical organization GHESKIO. Heart failure occurs when the heart muscle can no longer pump an adequate amount of blood throughout the body.

The study indicates that the nature of cardiovascular disease in Haiti, and perhaps other low- and middle...

Improving Care of Hospitalized Patients with HIV in Tanzania

March 11, 2024

Researchers at Weill Cornell Medicine have shown that three months of social worker follow-up support to people hospitalized with HIV in Tanzania had health benefits at low cost. The protocol shortened the time it took participants to attend an HIV clinic and to start on antiretroviral therapy after discharge.

However, the study published in JAMA on Mar. 6 found that the care benefits didn’t translate...

Weill Cornell Medicine Showcases Medical Education Facilities to Support Tecnológico de Monterrey’s Campus Planning

March 7, 2024

A delegation from Tecnológico de Monterrey in Mexico visited Weill Cornell Medicine on March 7, 2024, as part of the university’s planning for new academic and research facilities for its School of Medicine and Health Sciences. The delegation was led by Juan Pablo Murra, Rector of Higher Education, Dr. Luis Alonso Herrera, Dean of the School of Medicine and Health Sciences, Jessica González de Cosio, Strategic Planning Director and Health Sciences Campus Project Leader, along with other...

Drug-Resistant Tuberculosis Responds Rapidly to Bedaquiline-based Second-Line Therapy

February 27, 2024

Patients who have drug-resistant tuberculosis (TB) have a similar microbiological response to bedaquiline-based second-line medications as patients with drug-sensitive TB taking first-line regimens, according to researchers at Weill Cornell Medicine in New York and GHESKIO in Haiti. Second-line medications are those that are given when one or more of the drugs given first for the disease are not effective. The research could have implications for...